You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Proteasome Inhibitors

Showing 1 - 25 of 4,315
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Durham (Opaganib)

Terminated
Has Results
  • Multiple Myeloma
  • Durham, North Carolina
    Duke University Medical Center
May 24, 2021

Relapsed/Refractory Multiple Myeloma Trial in Worldwide (Placebo, Bortezomib, Dexamethasone)

Completed
  • Relapsed/Refractory Multiple Myeloma
  • Placebo
  • +3 more
  • Aurora, Colorado
  • +96 more
Aug 22, 2022

Kidney Transplantation, End Stage Kidney Disease (ESRD) Trial in Chicago (Belatacept Injection)

Recruiting
  • Kidney Transplantation
  • End Stage Kidney Disease (ESRD)
  • Belatacept Injection
  • Chicago, Illinois
    University of Chicago
May 13, 2022

Based on Maintenance Therapy Post Autologous Stem Cell

Recruiting
  • Multiple Myeloma
  • Autologous Stem Cell Transplant
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Jul 27, 2022

CIPN and it's Impact on Quality of Life in Patients Receiving

Not yet recruiting
  • Chemotherapy-induced Peripheral Neuropathy
    • (no location specified)
    Apr 24, 2023

    Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Carfilzomib, Cyclophosphamide, Dexamethasone)

    Not yet recruiting
    • Multiple Myeloma in Relapse
    • Multiple Myeloma, Refractory
    • (no location specified)
    Jun 8, 2023

    Proteasome Inhibition

    Completed
    • Heart Failure
    • Multiple Myeloma
      • Philadelphia, Pennsylvania
      • +1 more
      Sep 10, 2020

      Relapsed/Refractory Multiple Myeloma Trial in Benowa (ISB 2001)

      Not yet recruiting
      • Relapsed/Refractory Multiple Myeloma
      • ISB 2001
      • Benowa, Queensland, Australia
        Pindara Private Hospital
      May 18, 2023

      Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • Acute Lymphoblastic Leukemia With Failed Remission
      • São Paulo, SP, Brazil
        Instituto do Cancer do Estado de Sao Paulo
      Sep 12, 2023

      Multiple Myeloma Trial in Italy, Switzerland (Nelfinavir, Lenalidomide, Dexamethasone)

      Terminated
      • Multiple Myeloma
      • Milano, Italy
      • +10 more
      Jul 4, 2022

      Relapsed/Refractory Multiple Myeloma Trial in Australia, United States (ISB 1442 SC injection escalating doses, ISB 1442 SC

      Not yet recruiting
      • Relapsed/Refractory Multiple Myeloma
      • ISB 1442 SC injection escalating doses
      • ISB 1442 SC injection at RP2D
      • New York, New York
      • +5 more
      Jun 17, 2022

      Cardiovascular Complications of Carfilzomib Treatment

      Active, not recruiting
      • Multiple Myeloma
        • Athens, Greece
          Department of Clinical Therapeutics, "Alexandra" General Hospita
        Apr 27, 2021

        Bendamustine, Multiple Myeloma Trial in Shenyang (Bendamustine)

        Recruiting
        • Bendamustine
        • Multiple Myeloma
        • Shenyang, Liaoning, China
          Shengjing Hospital of China Medical University
        Aug 7, 2021

        New Echocardiographic Indicators in Treatment of Primary

        Not yet recruiting
        • Multiple Myeloma
        • Chemotherapy and/or autologous hematopoietic stem cell transplantation
        • (no location specified)
        Sep 18, 2023

        Multiple Myeloma in Relapse Trial in Finland, Sweden (Carfilzomib for Inj 60 milligram (MG), Elotuzumab 400 MG, Dexamethasone)

        Active, not recruiting
        • Multiple Myeloma in Relapse
        • Carfilzomib for Inj 60 milligram (MG)
        • +2 more
        • Helsinki, Finland
        • +7 more
        Mar 14, 2022

        Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial run by the

        Not yet recruiting
        • Multiple Myeloma
        • +2 more
        • 18F-fluciclovine injection
        • 18F-FDG PET/CT
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Oct 31, 2023

        Multiple Myeloma, Auto Stem Cell Transplant Trial in Hackensack (Bortezomib)

        Active, not recruiting
        • Multiple Myeloma
        • Auto Stem Cell Transplant
        • Hackensack, New Jersey
          John Theurer Cancer Center @ Hackensack University Medical Cente
        Dec 23, 2022

        Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome Trial in Atlanta (MLN9708)

        Completed
        Has Results
        • Acute Leukemia
        • +4 more
        • Atlanta, Georgia
          Northside Hospital
        Sep 1, 2021

        Relapse/Refractory Multiple Myeloma Trial in China (ATG-010)

        Completed
        • Relapse/Refractory Multiple Myeloma
        • Beijing, Beijing, China
        • +16 more
        Jul 27, 2022

        Multiple Myeloma Trial in Netherlands (Iberdomide plus low-dose cyclophosphamide and dexamethasone)

        Recruiting
        • Multiple Myeloma
        • Iberdomide plus low-dose cyclophosphamide and dexamethasone
        • Alkmaar, Netherlands
        • +8 more
        Oct 5, 2021

        Multiple Myeloma, High-Risk Cancer Trial in Montreal (Bortezomib following nonmyeloablative allogeneic transplant)

        Active, not recruiting
        • Multiple Myeloma
        • High-Risk Cancer
        • Bortezomib following nonmyeloablative allogeneic transplant
        • Montreal, Quebec, Canada
          Hôpital Maisonneuve-Rosemont
        Aug 22, 2022

        Mantle-Cell Lymphoma Trial in United States (Ixazomib, Ibrutinib)

        Active, not recruiting
        • Mantle-Cell Lymphoma
        • Atlanta, Georgia
        • +13 more
        Nov 17, 2022

        Multiple Myeloma, Myeloma Multiple, Kahler Disease Trial in United States (Selinexor, Dexamethasone Oral, Daratumumab)

        Recruiting
        • Multiple Myeloma
        • +6 more
        • Tucson, Arizona
        • +9 more
        Jan 5, 2022

        Multiple Myeloma, Pneumococcal Infection, Febrile Neutropenia Trial in Minsk (Vaccination with pneumococcal conjugate vaccine

        Enrolling by invitation
        • Multiple Myeloma
        • +3 more
        • Vaccination with pneumococcal conjugate vaccine (PCV13)
        • Standard Antibacterial Prophylaxis
        • Minsk, Belarus
          Minsk Scientific Practical Center of Surgery, Transplantation an
        Sep 1, 2020

        Multiple Myeloma Trial in Worldwide (Iberdomide)

        Recruiting
        • Multiple Myeloma
        • Nantes, France
        • +3 more
        Aug 16, 2022